117 related articles for article (PubMed ID: 2249997)
61. The role of factor VIII in the activation of human blood coagulation factor X by activated factor IX.
Mertens K; van Wijngaarden A; Bertina RM
Thromb Haemost; 1985 Oct; 54(3):654-60. PubMed ID: 3937263
[TBL] [Abstract][Full Text] [Related]
62. The role of amino-terminal residues of the heavy chain of factor IXa in the binding of its cofactor, factor VIIIa.
Hamaguchi N; Bajaj SP; Smith KJ; Stafford DW
Blood; 1994 Sep; 84(6):1837-42. PubMed ID: 8080989
[TBL] [Abstract][Full Text] [Related]
63. Factor IXa enhances reconstitution of factor VIIIa from isolated A2 subunit and A1/A3-C1-C2 dimer.
Lamphear BJ; Fay PJ
J Biol Chem; 1992 Feb; 267(6):3725-30. PubMed ID: 1740424
[TBL] [Abstract][Full Text] [Related]
64. Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation.
Baroni M; Pavani G; Pinotti M; Branchini A; Bernardi F; Camire RM
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1351-6. PubMed ID: 26012870
[TBL] [Abstract][Full Text] [Related]
65. The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX.
Lenting PJ; van de Loo JW; Donath MJ; van Mourik JA; Mertens K
J Biol Chem; 1996 Jan; 271(4):1935-40. PubMed ID: 8567641
[TBL] [Abstract][Full Text] [Related]
66. Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets.
Saenko EL; Scandella D; Yakhyaev AV; Greco NJ
J Biol Chem; 1998 Oct; 273(43):27918-26. PubMed ID: 9774404
[TBL] [Abstract][Full Text] [Related]
67. The assembly of the factor X-activating complex on activated human platelets.
Ahmad SS; London FS; Walsh PN
J Thromb Haemost; 2003 Jan; 1(1):48-59. PubMed ID: 12871539
[TBL] [Abstract][Full Text] [Related]
68. Factor VIIIa A2 subunit residues 558-565 represent a factor IXa interactive site.
Fay PJ; Beattie T; Huggins CF; Regan LM
J Biol Chem; 1994 Aug; 269(32):20522-7. PubMed ID: 8051150
[TBL] [Abstract][Full Text] [Related]
69. Factor IX Fukuoka. Substitution of ASN92 by His in the second epidermal growth factor-like domain results in defective interaction with factors VIIa/X.
Nishimura H; Takeya H; Miyata T; Suehiro K; Okamura T; Niho Y; Iwanaga S
J Biol Chem; 1993 Nov; 268(32):24041-6. PubMed ID: 8226948
[TBL] [Abstract][Full Text] [Related]
70. The role of human factor X activation peptide in activation of factor X by factor IXa.
Iino M; Takeya H; Nishioka J; Nakagaki T; Tamura K; Suzuki K
J Biochem; 1994 Aug; 116(2):335-40. PubMed ID: 7822251
[TBL] [Abstract][Full Text] [Related]
71. Experimental and theoretical evidence supporting the role of Gly363 in blood coagulation factor IXa (Gly193 in chymotrypsin) for proper activation of the proenzyme.
Bajaj SP; Spitzer SG; Welsh WJ; Warn-Cramer BJ; Kasper CK; Birktoft JJ
J Biol Chem; 1990 Feb; 265(5):2956-61. PubMed ID: 2303434
[TBL] [Abstract][Full Text] [Related]
72. Properties of the factor Xa binding site on human platelets.
Miletich JP; Jackson CM; Majerus PW
J Biol Chem; 1978 Oct; 253(19):6908-16. PubMed ID: 690132
[TBL] [Abstract][Full Text] [Related]
73. Factor IXa protects factor VIIIa from activated protein C. Factor IXa inhibits activated protein C-catalyzed cleavage of factor VIIIa at Arg562.
Regan LM; Lamphear BJ; Huggins CF; Walker FJ; Fay PJ
J Biol Chem; 1994 Apr; 269(13):9445-52. PubMed ID: 8144529
[TBL] [Abstract][Full Text] [Related]
74. Residues Phe342-Asn346 of activated coagulation factor IX contribute to the interaction with low density lipoprotein receptor-related protein.
Rohlena J; Kolkman JA; Boertjes RC; Mertens K; Lenting PJ
J Biol Chem; 2003 Mar; 278(11):9394-401. PubMed ID: 12522212
[TBL] [Abstract][Full Text] [Related]
75. Reactivity of bovine blood coagulation factor IXa beta, factor Xa beta, and factor XIa toward fluorogenic peptides containing the activation site sequences of bovine factor IX and factor X.
Castillo MJ; Kurachi K; Nishino N; Ohkubo I; Powers JC
Biochemistry; 1983 Mar; 22(5):1021-9. PubMed ID: 6601494
[TBL] [Abstract][Full Text] [Related]
76. Factor IXa inhibition by protease nexin-2/amyloid beta-protein precursor on phospholipid vesicles and cell membranes.
Schmaier AH; Dahl LD; Hasan AA; Cines DB; Bauer KA; Van Nostrand WE
Biochemistry; 1995 Jan; 34(4):1171-8. PubMed ID: 7827067
[TBL] [Abstract][Full Text] [Related]
77. Localization of factor IXa and factor VIIIa interactive sites.
O'Brien LM; Medved LV; Fay PJ
J Biol Chem; 1995 Nov; 270(45):27087-92. PubMed ID: 7592960
[TBL] [Abstract][Full Text] [Related]
78. Residues 88-109 of factor IXa are important for assembly of the factor X activating complex.
Wilkinson FH; London FS; Walsh PN
J Biol Chem; 2002 Feb; 277(8):5725-33. PubMed ID: 11726655
[TBL] [Abstract][Full Text] [Related]
79. An ordered sequential mechanism for Factor IX and Factor IXa binding to platelet receptors in the assembly of the Factor X-activating complex.
Yang X; Walsh PN
Biochem J; 2005 Aug; 390(Pt 1):157-67. PubMed ID: 15755260
[TBL] [Abstract][Full Text] [Related]
80. Protease and EGF1 domains of factor IXa play distinct roles in binding to factor VIIIa. Importance of helix 330 (helix 162 in chymotrypsin) of protease domain of factor IXa in its interaction with factor VIIIa.
Mathur A; Bajaj SP
J Biol Chem; 1999 Jun; 274(26):18477-86. PubMed ID: 10373456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
